<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <title>Clinicians | LiquidMammo™</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <link rel="stylesheet" href="assets/css/styles.css" />
  <link rel="icon" href="/favicon.png" type="image/png" />
</head>
<body>
<header class="container"><nav><a href="index.html">← Home</a></nav></header>
<main class="container">
  <h1>For Clinicians</h1>
  <p>LiquidMammo is a microRNA‑based liquid biopsy designed to complement imaging. The reporting provides a malignancy probability estimate and signature‑pattern insights to help guide next steps (biopsy/imaging remain confirmatory).</p>

  <h2>Clinical context</h2>
  <ul>
    <li>False‑negatives occur in mammography (≈1 in 8 overall) and are more likely in dense breasts.</li>
    <li>False‑negative rates have increased in large U.S. datasets over recent years.</li>
    <li>Detection yield with mammography is typically 2–7 cancers per 1,000 screens, with lower yield in younger/dense‑breasted cohorts.</li>
    <li>False‑positive burden over a decade is substantial (≥1 false positive for ~50–60% of screened women).</li>
  </ul>

  <h2 id="enroll">Enrollment</h2>
  <p>Email <a href="mailto:info@multiomics.health?subject=Clinician%20Enrollment%20%E2%80%93%20LiquidMammo">info@multiomics.health</a> for onboarding (ordering process, reporting format, and kit logistics).</p>
</main>
<footer class="container small">© <script>document.write(new Date().getFullYear())</script> MultiOmics Inc.</footer>
</body>

</html>
